Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- NIH/AHRQ Application Submission/Resubmission Policy
National Institutes of Health - NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2018-2019
National Institutes of Health - Update on NIHs Next Generation Researchers Initiative (NGRI) Policy on Early Established Investigators (EEIs)
National Institutes of Health - Notice of Additional Guidance for Alzheimer's Clinical Trials Consortium (ACTC) Applicants
National Institute on Aging - NIAID T32 and T35 Training Grants Maximum Number of Trainee Slots
National Institute of Allergy and Infectious Diseases - Notice of Change in Key Dates in PA-18-842 "Administrative Supplements to Support Cancer Disparity Collaborative Research"
National Cancer Institute - NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator
National Cancer Institute - Update on the National Cancer Institute (NCI) "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing "
National Cancer Institute - Request for Information (RFI): Strategies for Advancing Sepsis Research Supported by NIGMS
National Institute of General Medical Sciences - Notice of Change of Application Due Date for RFA-HD-19-018: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Clarification of AIDS Receipt Dates for PAR-18-844-Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of Change of Key Dates to RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"
National Heart, Lung, and Blood Institute - Confidentiality in AHRQ-Supported Research
Agency for Healthcare Research and Quality - Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
National Institute of Mental Health - Notice of Intent to Publish a Funding Opportunity Announcement for Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)
National Institute of Mental Health - Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01- Clinical Trial Optional)
National Institute of Nursing Research - Notice of Intent to Publish a Funding Opportunity Announcement for End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)
National Institute of Nursing Research - Notice of Intent to Publish a Funding Opportunity Announcement for NINR Clinical Trial Planning Grant (R34- Clinical Trial Optional)
National Institute of Nursing Research - Notice of Intent to Publish a Funding Opportunity Announcement for Analytical and Clinical Validation of Biomarkers, Biomarker Signatures, and Endpoints for Pain Indications (R61/R33)
National Institute of Neurological Disorders and Stroke - Soliciting Feedback on the BRAIN Initiative
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health - Notice of Change of Requirements and Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
National Institute of Neurological Disorders and Stroke
National Institute on Drug Abuse - Notification that NINDS will Accept Postdoctoral Fellowship Applications (F32; PAR-16-458) in October 2018 from all Potential Applicants who Meet the Eligibility Requirements for the August 2018 Due Date
National Institute of Neurological Disorders and Stroke - Notice Announcing Partnership Opportunity for Device-Based Clinical Studies Issued for the Stimulating Peripheral Activity to Relieve Conditions Program
Office of Strategic Coordination (Common Fund) - Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke - Notice of Modification to RFA-TR-18-020 Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences
Requests for Applications
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
National Institute on Aging
- HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases. - Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
National Human Genome Research Institute
- Molecular Atlas of Lung Development Program (LungMAP) Phase 2 Research Centers (U01- Clinical Trial Not Allowed)
- Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Clinical Trial Not Allowed)
- Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
- Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
- Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
- Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
- Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Program Announcements
- Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
National Human Genome Research Institute
. - Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
National Human Genome Research Institute
National Institute of Mental Health
. - BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)
- BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
- Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)
- Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
- Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
Office of Dietary Supplements
- Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
National Cancer Institute
- Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)
National Institute on Aging
National Institute of Nursing Research
- Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
National Institute on Aging
- Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu